Journal
RHEUMATOLOGY
Volume 57, Issue 4, Pages 596-605Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kex189
Keywords
varicella zoster virus; VZV; varicella; chickenpox; zoster; shingles; immunosuppressed; varicella zoster immunoglobulin; VZIG; contact; infection; acyclovir; antiviral; vaccine
Categories
Funding
- Sanofi-Pasteur
- MSD
Ask authors/readers for more resources
Chickenpox and shingles can be more severe and occasionally life threatening in immunosuppressed patients. As such, some groups warrant a more detailed history, serological testing and consideration of prophylaxis following contact with the virus. Active disease may also require more aggressive treatment with antivirals. Guidance for the use of varicella zoster immunoglobulin has recently been updated by Public Health England with important implications for rheumatology patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available